PuraPharm Corporation Limited (HKG:1498)
0.2440
-0.0060 (-2.40%)
Sep 18, 2026, 2:08 PM HKT
PuraPharm Corporation Revenue
PuraPharm Corporation had revenue of 159.67M HKD in the half year ending June 30, 2026, a decrease of -23.10%. This brings the company's revenue in the last twelve months to 323.49M, down -6.71% year-over-year. In the year 2025, PuraPharm Corporation had annual revenue of 336.11M, down -12.03%.
Revenue (ttm)
323.49M
Revenue Growth
-6.71%
P/S Ratio
0.40
Revenue / Employee
703.24K
Employees
460
Market Cap
130.55M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 336.11M | -45.98M | -12.03% |
| Dec 31, 2024 | 382.09M | -24.77M | -6.09% |
| Dec 31, 2023 | 406.86M | -41.21M | -9.20% |
| Dec 31, 2022 | 448.07M | -211.52M | -32.07% |
| Dec 31, 2021 | 659.59M | 57.78M | 9.60% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Zhongzhi Pharmaceutical Holdings | 1.90B |
| Shenzhen Neptunus Interlong Bio-technique Company | 1.05B |
| Kontafarma China Holdings | 845.33M |
| Wai Yuen Tong Medicine Holdings | 683.44M |
| Qianhai Health Holdings | 453.03M |
| Tianda Pharmaceuticals | 350.53M |
| Fusen Pharmaceutical Company | 318.79M |
| Sanai Health Industry Group Company | 95.36M |